• 1. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

Research Brief on 6-(Dimethoxymethyl)-2,3-dimethoxypyridine (CAS: 1142191-61-4) in Chemical Biology and Pharmaceutical Applications

6-(Dimethoxymethyl)-2,3-dimethoxypyridine (CAS: 1142191-61-4) is a pyridine derivative that has recently garnered attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This compound, characterized by its dimethoxymethyl and dimethoxy functional groups, serves as a versatile intermediate in the synthesis of more complex molecules, particularly in drug discovery and development. Recent studies have explored its role in modulating biological pathways, its pharmacokinetic properties, and its potential as a scaffold for novel therapeutics.

One of the key areas of interest in recent research has been the compound's utility as a building block in the synthesis of kinase inhibitors. Kinases are a critical target class in oncology and inflammatory diseases, and the structural features of 6-(Dimethoxymethyl)-2,3-dimethoxypyridine make it a promising candidate for the development of selective kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibited potent inhibitory activity against specific kinases involved in cancer cell proliferation, with improved selectivity profiles compared to existing inhibitors.

Another significant application of 6-(Dimethoxymethyl)-2,3-dimethoxypyridine lies in its role in the development of central nervous system (CNS) therapeutics. The compound's ability to cross the blood-brain barrier, as evidenced by recent pharmacokinetic studies, has made it a valuable scaffold for designing drugs targeting neurological disorders. Research published in ACS Chemical Neuroscience highlighted its use in the synthesis of novel neuroprotective agents, showing efficacy in preclinical models of neurodegenerative diseases such as Alzheimer's and Parkinson's.

In addition to its therapeutic potential, recent advancements in synthetic chemistry have focused on optimizing the production of 6-(Dimethoxymethyl)-2,3-dimethoxypyridine. A 2024 study in Organic Process Research & Development detailed a scalable and cost-effective synthetic route, addressing previous challenges related to yield and purity. This development is expected to facilitate broader adoption of the compound in both academic and industrial research settings.

Despite these promising findings, challenges remain in fully elucidating the compound's mechanism of action and optimizing its pharmacological properties. Ongoing research aims to further explore its interactions with biological targets and to refine its derivatives for enhanced efficacy and safety. The continued investigation into 6-(Dimethoxymethyl)-2,3-dimethoxypyridine underscores its potential as a cornerstone in the development of next-generation therapeutics, bridging the gap between chemical biology and clinical applications.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)